UAE

The agreements aim to strengthen national health security and create a coordinated response system that can manage future emergencies more effectively.

Under this agreement, CellSave Arabia will act as the exclusive provider of cord blood, cord tissue, placental tissue, cord vessel, and amnion preservation services.

The care model integrates internationally recognised diagnostic frameworks such as ADOS for autism assessment, WISC for cognitive evaluation, and Conners Rating Scales for ADHD screening.

The designation highlights Abu Dhabi’s expanding role in global health security, particularly in strengthening systems that detect, track, and respond to infectious disease threats.

The agreement was formalised during a signing ceremony held at ADCAN Pharma’s advanced manufacturing facility in Abu Dhabi, bringing together senior leadership from both organisations and key healthcare stakeholders.

Neurodiversity remains a central focus, particularly in identifying autism and ADHD in girls, women, and high-achieving adults who often mask symptoms for years before receiving support.

The researchers designed the device to work seamlessly with existing medical imaging technologies, including ultrasound and CT scans.

The facility will occupy approximately 3,000 square metres and will comprise a ground floor, five upper levels, and a rooftop, reaching a height of 27.75 metres.

Under the new agreement, EDE and Novo Nordisk will work together to enhance pharmaceutical supply chain security by increasing in-country value creation and expanding strategic partnerships that help maintain a steady supply of medicines.

The capsule uses advanced light-absorption technology to detect blood in the upper gastrointestinal tract and wirelessly transmits the findings to an external receiver, which is monitored by healthcare professionals.